The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, ...

Social determinants of health affect whether a patient undergoes cross-linking or transplantation for keratoconus, according ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for ...

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...

Beckman said it is important to treat keratoconus with corneal collagen crosslinking early to prevent vision loss, although ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...

The FDA approval of Epioxa is based on results from two prospective, randomized, multicenter, double-masked, Phase 3 pivotal trials that randomized a total of over 400 patients. Both trials ...

In an interview conducted by Ophthalmology Times on behalf of Managed Healthcare Executive, Beckman listed some of the ...

Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

The U.S. Food and Drug Administration has approved a new eye therapy from Glaukos Corp , giving patients a less painful ...

Rubbing your eyes, though seemingly harmless, can lead to serious health issues. It increases infection risk, damages the ...